Vleuten, Netherlands

R Jeroen Pasterkamp

This inventor holds 1 USPTO granted patent. Top assignee: Interna Technologies B.v.. Active years: 2022.

IDiyas Innovation Intelligence. (2026). Inventor Profile: R Jeroen Pasterkamp. Retrieved from https://idiyas.com/inventor/r-jeroen-pasterkamp

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 5.0

ph-index = 1


Company Filing History:


Years Active: 2022

Loading Chart...
1 patent (USPTO):Explore Patents

Title: R Jeroen Pasterkamp: Innovator in Neuronal Therapeutics

Introduction

R Jeroen Pasterkamp is a notable inventor based in Vleuten, Netherlands. He has made significant contributions to the field of neuroscience through his innovative work on miRNA molecules. His research focuses on developing diagnostic and therapeutic solutions for conditions associated with neuronal deficiencies.

Latest Patents

R Jeroen Pasterkamp holds a patent for a miRNA molecule, equivalent, antagomir, or source thereof for treating and/or diagnosing a condition and/or a disease associated with neuronal deficiency or for neuronal (re)generation. This invention relates to the diagnostic and therapeutic uses of a miRNA molecule, an equivalent, or a source thereof in addressing neuronal deficiencies and related diseases.

Career Highlights

Pasterkamp is associated with Interna Technologies B.V., where he continues to advance his research and development efforts. His work has garnered attention for its potential impact on treating neurological disorders.

Collaborations

He collaborates with esteemed colleagues, including Eljo Y Van Battum and Vamshi R Vangoor, to further enhance the scope and application of his inventions.

Conclusion

R Jeroen Pasterkamp's innovative contributions to the field of neuroscience highlight the importance of research in developing effective treatments for neuronal deficiencies. His work continues to pave the way for advancements in therapeutic solutions.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…